1. Home
  2. MDIA vs SCLX Comparison

MDIA vs SCLX Comparison

Compare MDIA & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mediaco Holding Inc.

MDIA

Mediaco Holding Inc.

N/A

Current Price

$0.65

Market Cap

50.0M

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$6.90

Market Cap

52.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MDIA
SCLX
Founded
2019
2011
Country
United States
United States
Employees
N/A
30
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.0M
52.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
MDIA
SCLX
Price
$0.65
$6.90
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
11.1K
28.4K
Earning Date
04-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
80.00
N/A
EPS
N/A
N/A
Revenue
$95,571,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
195.05
N/A
52 Week Low
$0.54
$0.18
52 Week High
$1.60
$34.27

Technical Indicators

Market Signals
Indicator
MDIA
SCLX
Relative Strength Index (RSI) 50.86 33.34
Support Level $0.56 $4.56
Resistance Level $0.65 $7.50
Average True Range (ATR) 0.03 0.67
MACD 0.00 -0.07
Stochastic Oscillator 43.59 4.30

Price Performance

Historical Comparison
MDIA
SCLX

About MDIA Mediaco Holding Inc.

MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: